Hyperbaric Oxygen Therapy (HBOT)
Defines medical necessity and investigational indications for systemic hyperbaric oxygen therapy and excludes topical HBOT; lists prior authorization rules and relevant CPT/HCPCS/ICD codes for commercial members (HMO, POS, PPO, Indemnity). This is Part 1 of 3 of the policy.
Treatment of necrotizing soft tissue infections, idiopathic sudden sensorineural hearing loss, and central retinal artery occlusion added to medically necessary statement.
Coverage for compromised skin grafts and flaps added to medically necessary statement.
Prior authorization requirement clarified: Prior Authorization not required effective 6/1/2022.
Coding information and ICD-10 procedure/diagnosis codes updated and clarified across multiple dates (2014-2024).
Annual policy reviews and literature updates through June 7, 2024; references and clinical input added.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.